Cynosure Group’s iShares MSCI USA Quality Factor ETF QUAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Sell
10,528
-9,739
-48% -$2.04M 0.35% 27
2026
Q1
$3.89M Buy
20,267
+251
+1% +$50.3K 0.49% 33
2025
Q4
$3.98M Sell
20,016
-26,521
-57% -$5.21M 0.4% 35
2025
Q3
$9.05M Buy
46,537
+47
+0.1% +$8.82K 0.98% 21
2025
Q2
$8.5M Buy
46,490
+176
+0.4% +$30.4K 0.96% 20
2025
Q1
$7.91M Sell
46,314
-1,387
-3% -$248K 1.09% 18
2024
Q4
$8.49M Sell
47,701
-1,717
-3% -$312K 1.27% 17
2024
Q3
$8.86M Sell
49,418
-3,327
-6% -$577K 1.29% 18
2024
Q2
$9.01M Sell
52,745
-59
-0.1% -$9.69K 1.45% 14
2024
Q1
$8.68M Buy
52,804
+68
+0.1% +$10.6K 1.56% 14
2023
Q4
$7.77M Buy
52,736
+1,661
+3% +$230K 1.4% 15
2023
Q3
$6.73M Buy
51,075
+1,313
+3% +$179K 2.07% 12
2023
Q2
$6.71M Buy
+49,762
New +$6.33M 2.02% 14

Other funds holding QUAL

Cynosure Group's QUAL Position: Q2 2026 in Review

Cynosure Group reduced its iShares MSCI USA Quality Factor ETF (QUAL) stake by 48% in Q2 2026, selling an estimated $2.04M and leaving 10,528 shares worth $2.31M. The position accounts for 0.35% of the portfolio, ranked #27.

Cynosure Group first reported a position in QUAL in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.05M in Q3 2025. 1,644 funds tracked by Wall St. Rank hold QUAL as of Q2 2026.

  • Cynosure Group held 10,528 shares of iShares MSCI USA Quality Factor ETF worth $2.31M as of Q2 2026.
  • Cynosure Group sold 9,739 iShares MSCI USA Quality Factor ETF shares in Q2 2026, an estimated $2.04M.
  • iShares MSCI USA Quality Factor ETF made up 0.35% of Cynosure Group's portfolio in Q2 2026, its #27 holding.
  • Cynosure Group first reported a position in iShares MSCI USA Quality Factor ETF in Q2 2023 and has held it in 13 quarters since.
  • Cynosure Group's iShares MSCI USA Quality Factor ETF position peaked at $9.05M in Q3 2025.
  • 1,644 funds tracked by Wall St. Rank held iShares MSCI USA Quality Factor ETF as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.